Health Care [ 1/12 ] | Health Care Equipment & Supplies [ 17/74 ]
NYSE MKT | Common Stock
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally.
The company offers robotic magnetic navigation (RMN) systems, such as Genesis RMN, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites; and GenesisX RMN System, which is designed to enhance the accessibility of Robotic Magnetic Navigation by reducing the lengthy construction cycle necessary to install prior generation RMN systems.
It also offers Odyssey, a Synchrony and SynX Solution offer integrated, real-time information solution to manage, control, record and share procedures across networks; and x-ray systems.
In addition, the company offers disposables and other accessories, including MAGiC catheter, a robotically navigated magnetic ablation catheter designed to perform minimally invasive cardiac ablation procedures; MAGiC Sweep, a mapping catheter; QuikCAS, an automated catheter advancement single-use disposable device; iCONNECT; and V-CAS devices.
Further, it provides interventional devices under the Map-iT, MAGiC, and EMAGIN brands, and other related devices.
It markets its products through direct sales force, distributors, and sales agents.
Stereotaxis, Inc. was incorporated in 1990 and is based in Saint Louis, Missouri.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| May 12, 26 | -0.06 Increased by +10.86% | -0.06 Decreased by -10.05% |
| Mar 9, 26 | -0.06 Increased by +33.33% | -0.06 |
| Nov 11, 25 | -0.07 Increased by +12.50% | -0.06 Decreased by -16.67% |
| Aug 7, 25 | -0.05 Increased by +28.57% | -0.07 Increased by +28.57% |
| May 12, 25 | -0.07 Decreased by -16.67% | -0.07 |
| Mar 3, 25 | -0.09 Decreased by -28.57% | -0.07 Decreased by -38.46% |
| Nov 11, 24 | -0.08 Decreased by -14.29% | -0.05 Decreased by -60.00% |
| Aug 12, 24 | -0.07 Increased by 0.00% | -0.05 Decreased by -40.00% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Mar 31, 26 | 6.29 M Decreased by -15.81% | -5.86 M Decreased by -0.65% | Decreased by -93.16% Decreased by -19.55% |
| Dec 31, 25 | 8.64 M Increased by +36.31% | -5.53 M Increased by +26.40% | Decreased by -64.00% Increased by +46.01% |
| Sep 30, 25 | 7.46 M Decreased by -18.83% | -6.46 M Decreased by -4.41% | Decreased by -86.59% Decreased by -28.64% |
| Jun 30, 25 | 8.80 M Increased by +95.42% | -3.83 M Increased by +34.41% | Decreased by -43.49% Increased by +66.44% |
| Mar 31, 25 | 7.47 M Increased by +8.60% | -5.82 M Decreased by -29.20% | Decreased by -77.93% Decreased by -18.96% |
| Dec 31, 24 | 6.34 M Increased by +38.88% | -7.51 M Decreased by -49.11% | Decreased by -118.53% Decreased by -7.36% |
| Sep 30, 24 | 9.20 M Increased by +17.91% | -6.19 M Decreased by -15.29% | Decreased by -67.31% Increased by +2.22% |
| Jun 30, 24 | 4.50 M Decreased by -42.72% | -5.83 M Decreased by -17.67% | Decreased by -129.56% Decreased by -105.42% |